Navigation Links
New Combo Treatment Extends Kidney Cancer Survival
Date:12/21/2007

Avastin plus interferon almost doubled patients' time without disease progression, study found

FRIDAY, Dec 21 (HealthDay News) -- A combination treatment with two drugs, Avastin (bevacizumab) plus interferon, extends the life of patients with kidney cancer, European researchers report.

"Based on the result of earlier trials, there is already considerable enthusiasm to use bevacizumab as a new drug for treating kidney cancer patients," noted Dr. Mayer Fishman, an assistant professor in the department of interdisciplinary oncology at the Moffitt Cancer Center of the University of South Florida in Tampa. He was not involved in the study.

Publication of large trials such as this can be expected to support the more widespread use of new drugs such as bevacizumab for kidney cancer therapy, Fishman said.

The study was funded by F. Hoffmann-La Roche Ltd., the maker of Avastin. It is published in the Dec. 22/29 issue of The Lancet.

In a phase III trial, Dr. Bernard Escudier from the Institute Gustave Roussy in Villejuif, France, and colleagues randomly assigned 649 patients with kidney cancer to receive Avastin and interferon or interferon plus a placebo.

Among those receiving combined therapy, 114 died compared with 137 of those receiving interferon alone. Moreover, patients taking Avastin plus interferon survived without any signs of disease progression for an average of 10.2 months. That's almost double the 5.4-month average progression-free survival for those on interferon alone.

"This treatment [bevacizumab plus interferon] is clearly comparable with the most active treatment, and with a very good safety profile, will provide new options for renal cancer patients," Escudier's group concluded.

As more and more targeted drugs are developed, and as more combinations are possible, and as immune treatments become more sophisticated, "optimism is building that we will see more a
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Radiation and drug combo helps boost efficacy of lung cancer treatment
2. Aerobic, Weight Training Combo Best Against Diabetes
3. New antibiotic drug combo to speed up treatment of tuberculosis
4. Drug Combo Helps Fight Marfan Syndrome
5. Drug Combo Blocks Pain Without Impairing Movement
6. Two-Drug Combo Fights Brain Tumors
7. CPR, Defibrillator Combo Boosts Cardiac Incident Survival
8. Drug Combo Boosts Multiple Myeloma Survival
9. Drug Combos Effective Against Rheumatoid Arthritis
10. Combo PET/CT Scan Helps Spot Breast Cancers Spread
11. Drug Combo With Antibiotic May Slow MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Combo Treatment Extends Kidney Cancer Survival
(Date:9/23/2014)... 23, 2014 Florida Hospital Zephyrhills ... renovated Women’s Health Center on Wednesday, September 24. ... the specially designed center offers a new level ... County. The Women’s Health Center offers comprehensive women’s ... labor and delivery through The Baby Place®, and ...
(Date:9/23/2014)... published studies found that FDG-PET technology is less ... in regions where infections like histoplasmosis or tuberculosis ... for cancer could lead to unnecessary tests and ... mortality. , Histoplasmosis and other fungal diseases ... in bird droppings and are found in soils. ...
(Date:9/23/2014)... Sinica, the preeminent academic institution in the Republic ... agreement to develop a unique educational and scientific ... to translate innovative technologies and commercially relevant discoveries ... Sept.12 in Taipei by Harris Lewin, vice chancellor ... Wong of Academia Sinica. The program will be ...
(Date:9/23/2014)... From first-hand experience, Matthew O'Farrell knows all about ... can be treated. , A medically retired Army veteran, ... platoon sustained multiple attacks resulting in five casualties. After ... PTSD and honorably discharged from the Army. , “I ... myself from my friends and family,” recalled O’Farrell, who ...
(Date:9/23/2014)... As a consumer in today’s world, ... It’s difficult to trust testimonials that are supplied by ... manipulate their customers into saying anything. , Consumer advocacy ... to lack in depth coverage on a particular market ... to fix this issue and focus on exposing the ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 2Health News:Florida Hospital Zephyrhills Celebrates Grand Opening of Women’s Health Center 3Health News:Study questions accuracy of lung cancer screens in some geographic regions 2Health News:Academia Sinica, UC Davis sign agreement on exchanges and tech transfer 2Health News:Virtual Reality software to help treat PTSD 2Health News:Virtual Reality software to help treat PTSD 3Health News:Consumer Health Reports Debuts Revolutionary Review Website 2
... in those who also have heart disease , TUESDAY, Aug. ... prostate cancer and who also have underlying heart disease may ... In fact, such hormone therapy may actually increase their odds ... attack or heart failure, use of hormone therapy for prostate ...
... ... Health System to stable, citing the health system,s "improving financial metrics" and "better-than-expected ... ... its outlook for Wellmont Health System to stable, citing the health system,s ...
... , SAN DIEGO, Aug. 25 CareFusion ... 500 index following the company,s planned spinoff from Cardinal Health on Aug. ... 1, coinciding with its first day of regular-way trading on the New ... "Our inclusion in the S&P 500 is a testament to our ...
... , , , ... the ideal time to honor the life of a beloved pet--yours or someone ... lost pet and also offer animal lovers an opportunity to improve the future ... are customized with the names of the pet owner and the pet ...
... the anti-cancer drug, experts say , TUESDAY, Aug. 25 (HealthDay ... lower the chances of developing the most common type of ... raises the risk of getting a more aggressive cancer in ... the finding is no reason to ditch the anti-cancer drug, ...
... , IRVINE, Calif., Aug. 25 Masimo ... and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that ... Report as one of ,America,s Best Children,s Hospitals, has completed ... , , Masimo SET has been clinically ...
Cached Medicine News:Health News:Hormone Therapy for Early Prostate Cancer Not Always Best 2Health News:Hormone Therapy for Early Prostate Cancer Not Always Best 3Health News:Standard & Poor's Upgrades Wellmont Outlook 2Health News:Standard & Poor's Upgrades Wellmont Outlook 3Health News:CareFusion Corp to be Included in S&P 500 Index 2Health News:Honor Spirit and Memory of a Special Pet During National Pet Memorial Month 2Health News:Tamoxifen May Up Risk of Second, More Aggressive Breast Cancer 2Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 2Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 3Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 4Health News:Childrens Hospital Los Angeles Completes Conversion to Masimo SET(R) Pulse Oximetry Technology 5
(Date:9/23/2014)... Sept. 23, 2014 The Pennsylvania State Police will ... 27, as part of National Prescription Drug Take-Back Day. ... Take-Back Day is a national initiative, conducted ... aimed at encouraging the public to dispose of expired, ... abuse and theft. From 10 a.m. to ...
(Date:9/23/2014)... Canada , September 23, 2014 ... and lifestyle related disorders and increasing number of foreign ... demand for probiotic in India ... as one of the most high growth potential markets ... concerns among consumers especially among the youth, changing food ...
(Date:9/23/2014)... 23, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... (NOL) from Health Canada to begin clinical trials ... lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  ... acute moderate to moderately severe pain. The Health ...
Breaking Medicine Technology:India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 2India Probiotic Market Pegged to Grow at Around 20% by 2019, Says TechSci Research 3KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
... , MOUNTAIN VIEW, Calif. , Feb. 16 ... it will host an investor/analyst meeting on Thursday, February 18, 2010 ... New York City . , The meeting will include presentations from: , ... James Cassella , PhD - SVP, Research and Development, ...
... , LAWRENCEVILLE, N.J. , Feb. 16 ... announced today that Wayne S. Mulcahy , Ph.D., ... A wholly owned subsidiary of Princeton Pharma Holdings LLC, ... unique products in ophthalmology and orphan diseases. , ...
Cached Medicine Technology:Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 2Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 3Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010 4Aton Pharma Appoints Dr. Wayne Mulcahy to Vice President, Clinical Operations 2
The Tano Asymmetrical Microforceps features an offset tip which allows optimal visualization along the entire tip length. Versatile tip design targets ILM, fine epiretinal membranes and diabetic or P...
Microforceps : Asymmetrical Endgripping Forceps...
Pic forceps design that is slightly curved; tips have special "surface treatment" for enhanced manipulation of the retina....
Microforceps : Eckardt Endgripping Forceps...
Medicine Products: